Ipca Laboratories Limited (NSE:IPCALAB)
India · Delayed Price · Currency is INR 1,327.00
-12.00 (-0.90%)
Oct 1, 2025, 3:30 PM IST
Ipca Laboratories Market Cap
Ipca Laboratories has a market cap or net worth of 336.74 billion as of October 2, 2025. Its market cap has decreased by -9.96% in one year.
Market Cap
336.74B
Enterprise Value
353.72B
Revenue
91.57B
Ranking
n/a
PE Ratio
43.25
Stock Price
1,327.00
Market Cap Chart
Since June 12, 2002, Ipca Laboratories's market cap has increased from 3.22B to 336.74B, an increase of 10,361.88%. That is a compound annual growth rate of 22.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2025 | 336.74B | -21.70% |
| Dec 31, 2024 | 430.08B | 52.29% |
| Dec 29, 2023 | 282.41B | 32.03% |
| Dec 30, 2022 | 213.90B | -22.18% |
| Dec 31, 2021 | 274.86B | -1.01% |
| Dec 31, 2020 | 277.65B | 93.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,825.26B |
| Divi's Laboratories | 1,510.38B |
| Cipla | 1,214.30B |
| Apollo Hospitals Enterprise | 1,065.30B |
| Mankind Pharma | 1,005.36B |
| Zydus Lifesciences | 988.02B |
| Fortis Healthcare | 732.16B |
| Alkem Laboratories | 648.64B |